
TY  - JOUR
TI  - Endocrine Surgery Program Abstracts
JO  - ANZ Journal of Surgery
VL  - 80
IS  - s1
SN  - 1445-1433
UR  - https://doi.org/10.1111/j.1445-2197.2010.05298_6.x
DO  - doi:10.1111/j.1445-2197.2010.05298_6.x
SP  - A25
EP  - A29
PY  - 2010
ER  - 

TY  - JOUR
TI  - Hapatopancreaticobiliary and Upper GI Surgery Program Abstracts
JO  - ANZ Journal of Surgery
VL  - 80
IS  - s1
SN  - 1445-1433
UR  - https://doi.org/10.1111/j.1445-2197.2010.05298_9.x
DO  - doi:10.1111/j.1445-2197.2010.05298_9.x
SP  - A42
EP  - A48
PY  - 2010
ER  - 

TY  - JOUR
TI  - Posters
JO  - Clinical Microbiology and Infection
VL  - 15
IS  - s4
SN  - 1198-743X
UR  - https://doi.org/10.1111/j.1469-0691.2009.02858.x
DO  - doi:10.1111/j.1469-0691.2009.02858.x
SP  - S107
EP  - S612
PY  - 2009
ER  - 

TY  - JOUR
TI  - Poster Session: Haemostasis and Thrombosis
JO  - British Journal of Haematology
VL  - 149
IS  - s1
SN  - 0007-1048
UR  - https://doi.org/10.1111/j.1365-2141.2010.08116_1.x
DO  - doi:10.1111/j.1365-2141.2010.08116_1.x
SP  - 27
EP  - 96
PY  - 2010
ER  - 

TY  - JOUR
TI  - BOOK REVIEWS
JO  - Medical Journal of Australia
JA  - Medical Journal of Australia
VL  - 2
IS  - 16
SN  - 0025-729X
UR  - https://doi.org/10.5694/j.1326-5377.1970.tb63150.x
DO  - doi:10.5694/j.1326-5377.1970.tb63150.x
SP  - 742
EP  - 748
PY  - 1970
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Journal of Thrombosis and Haemostasis
VL  - 3
IS  - s1
SN  - 1538-7933
UR  - https://doi.org/10.1111/j.1538-7836.2005.03000.x
DO  - doi:10.1111/j.1538-7836.2005.03000.x
SP  - H01
EP  - SYM90
PY  - 2005
ER  - 

TY  - JOUR
AU  - GRICE, KATHERINE
TI  - Sarcoidosis and Mycobacterium avium-intracellulare cutaneous abscesses
JO  - Clinical and Experimental Dermatology
VL  - 8
IS  - 3
SN  - 0307-6938
UR  - https://doi.org/10.1111/j.1365-2230.1983.tb01787.x
DO  - doi:10.1111/j.1365-2230.1983.tb01787.x
SP  - 323
EP  - 327
PY  - 1983
AB  - Summary Two Mycobacterium avium-intracellulare abscesses developed in a patient who had had multisystem sarcoidosis for 20 years. The mycobacterial abscesses appeared while she was being treated with prednisolone and azathioprine.
ER  - 

TY  - JOUR
AU  - Van Dyck, Lisa
AU  - Casaer, MichaÃ«l P.
AU  - Gunst, Jan
TI  - Autophagy and Its Implications Against Early Full Nutrition Support in Critical Illness
JO  - Nutrition in Clinical Practice
JA  - Nutrition in Clinical Practice
VL  - 33
IS  - 3
SN  - 0884-5336
UR  - https://doi.org/10.1002/ncp.10084
DO  - doi:10.1002/ncp.10084
SP  - 339
EP  - 347
KW  - enteral nutrition
KW  - autophagy
KW  - parenteral nutrition
KW  - nutrition support
KW  - critical illness
PY  - 2018
AB  - Abstract The timing, dose, and route of early nutrition support in critically ill patients have been highly controversial for years. Despite the association of a caloric deficit with adverse outcome, several recent large, randomized, controlled trials have demonstrated a prolongation of organ failure and increased muscle weakness with increasing doses of nutrition in the acute phase of critical illness. A potential explanation for the negative impact of early, full feeding on outcome is feeding-induced suppression of autophagy, a cellular repair process that is necessary to clear intracellular damage. Whether nutrition management in critically ill patients should be guided by its effects on autophagy is a topic of debate. Currently, however, autophagy cannot be monitored in clinical practice. Moreover, clinical management should be guided by high-quality randomized controlled trials, which currently do not support the use of early full nutrition support.
ER  - 

TY  - JOUR
TI  - Book reviews
JO  - Anaesthesia
VL  - 43
IS  - 7
SN  - 0003-2409
UR  - https://doi.org/10.1111/j.1365-2044.1988.tb06740.x
DO  - doi:10.1111/j.1365-2044.1988.tb06740.x
SP  - 616
EP  - 617
PY  - 1988
AB  - Book Reviewed in this article: Radiology for anaesthesia and critical care Edited by C.H. Murphy and M.H. Murphy. Complications in critical care medicine Edited by P.D. Lumbard and C.W. Bryan-Brown. Foundations of obstetric anaesthesia Edited by B.M. Morgan.
ER  - 

TY  - JOUR
TI  - Podium Presentation Abstracts
JO  - BJU International
JA  - BJU Int
VL  - 113
IS  - S4
SN  - 1464-4096
UR  - https://doi.org/10.1111/bju.12618
DO  - doi:10.1111/bju.12618
SP  - 1
EP  - 50
PY  - 2014
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Acta Anaesthesiologica Scandinavica
VL  - 35
IS  - s96
SN  - 0001-5172
UR  - https://doi.org/10.1111/j.1399-6576.1991.tb03411.x
DO  - doi:10.1111/j.1399-6576.1991.tb03411.x
SP  - 7
EP  - 227
PY  - 1991
ER  - 

AU  - Dieterle, Frank
AU  - Sistare, Frank D.
C7  - pp. 237-279
TI  - Biomarkers of Acute Kidney Injury
SN  - 9780470452240
UR  - https://doi.org/10.1002/9780470918562.ch10
DO  - doi:10.1002/9780470918562.ch10
SP  - 237-279
KW  - acute kidney injury
KW  - kidney safety biomarkers
KW  - functional biomarkers
KW  - leakage markers
KW  - expression markers
PY  - 1991
AB  - Summary This chapter contains sections titled: Introduction Novel Kidney Safety Biomarkers Newest Technologies and Achievements Around Kidney Safety Biomarkers Conclusion Summary Points
ER  - 

TY  - JOUR
TI  - Posters
JO  - Nephrology
JA  - Nephrology
VL  - 23
IS  - S3
SN  - 9780470452240
UR  - https://doi.org/10.1111/nep.13442
DO  - doi:10.1111/nep.13442
SP  - 71
EP  - 100
PY  - 2018
ER  - 

TY  - JOUR
TI  - AMERICAN TRANSPLANT CONGRESS 2012 ABSTRACTS
JO  - American Journal of Transplantation
VL  - 12
IS  - s3
SN  - 9780470452240
UR  - https://doi.org/10.1111/j.1600-6143.2012.04112.x
DO  - doi:10.1111/j.1600-6143.2012.04112.x
SP  - 27
EP  - 542
PY  - 2012
ER  - 

TY  - JOUR
AU  - Knerr, Ina
AU  - Weinhold, Natalie
AU  - Vockley, Jerry
AU  - Gibson, K. Michael
TI  - Advances and challenges in the treatment of branched-chain amino/keto acid metabolic defects
JO  - Journal of Inherited Metabolic Disease
JA  - J Inherit Metab Dis
VL  - 35
IS  - 1
SN  - 9780470452240
UR  - https://doi.org/10.1007/s10545-010-9269-1
DO  - doi:10.1007/s10545-010-9269-1
SP  - 29
EP  - 40
PY  - 2012
AB  - Summary Disorders of branched-chain amino/keto acid metabolism encompass diverse entities, including maple syrup urine disease (MSUD), the ?classical? organic acidurias isovaleric acidemia (IVA), propionic acidemia (PA), methylmalonic acidemia (MMA) and, among others, rarely described disorders such as 2-methylbutyryl-CoA dehydrogenase deficiency (MBDD) or isobutyryl-CoA dehydrogenase deficiency (IBDD). Our focus in this review is to highlight the biochemical basis underlying recent advances and ongoing challenges of long-term conservative therapy including precursor/protein restriction, replenishment of deficient substrates, and the use of antioxidants and anaplerotic agents which refill the Krebs cycle. Ongoing clinical assessments of affected individuals in conjunction with monitoring of disease-specific biochemical parameters remain essential. It is likely that mass spectrometry-based ?metabolomics? may be a helpful tool in the future for studying complete biochemical profiles and diverse metabolic phenotypes. Prospective studies are needed to test the effectiveness of adjunct therapies such as antioxidants, ornithine-alpha-ketoglutarate (OKG) or creatine in addition to specialized diets and to optimize current therapeutic strategies in affected individuals. With the individual life-time risk and degree of severity being unknown in asymptomatic individuals with MBDD or IBDD, instructions regarding risks for metabolic stress and fasting avoidance along with clinical monitoring are reasonable interventions at the current time. Overall, it is apparent that carefully designed prospective clinical investigations and multicenter cohort-controlled trials are needed in order to leverage that knowledge into significant breakthroughs in treatment strategies and appropriate approaches.
ER  - 

AU  - Campbell, Amy
C7  - pp. 151-176
TI  - Gastrointestinal Emergencies
SN  - 9780813810577
UR  - https://doi.org/10.1002/9781118785690.ch8
DO  - doi:10.1002/9781118785690.ch8
SP  - 151-176
PY  - 2012
ER  - 

TY  - JOUR
TI  - SARS abstracts
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 104
IS  - S3
SN  - 9780813810577
UR  - https://doi.org/10.1002/bjs.10531
DO  - doi:10.1002/bjs.10531
SP  - 7
EP  - 57
PY  - 2017
ER  - 

TY  - JOUR
AU  - Morris, C. G.
AU  - Low, J.
TI  - Metabolic acidosis in the critically ill: Part 2. Causes and treatment
JO  - Anaesthesia
VL  - 63
IS  - 4
SN  - 9780813810577
UR  - https://doi.org/10.1111/j.1365-2044.2007.05371.x
DO  - doi:10.1111/j.1365-2044.2007.05371.x
SP  - 396
EP  - 411
PY  - 2008
AB  - Summary The correct identification of the cause, and ideally the individual acid, responsible for metabolic acidosis in the critically ill ensures rational management. In Part 2 of this review, we examine the elevated (corrected) anion gap acidoses (lactic, ketones, uraemic and toxin ingestion) and contrast them with nonelevated conditions (bicarbonate wasting, renal tubular acidoses and iatrogenic hyperchloraemia) using readily available base excess and anion gap techniques. The potentially erroneous interpretation of elevated lactate signifying cell ischaemia is highlighted. We provide diagnostic and therapeutic guidance when faced with a high anion gap acidosis, for example pyroglutamate, in the common clinical scenario ?I can?t identify the acid ? but I know it's there'. The evidence that metabolic acidosis affects outcomes and thus warrants correction is considered and we provide management guidance including extracorporeal removal and fomepizole therapy.
ER  - 

TY  - JOUR
TI  - E-Poster Presentations (Oral) | APDW 2019
JO  - Journal of Gastroenterology and Hepatology
JA  - Journal of Gastroenterology and Hepatology
VL  - 34
IS  - S3
SN  - 9780813810577
UR  - https://doi.org/10.1111/jgh.14879
DO  - doi:10.1111/jgh.14879
SP  - 72
EP  - 582
PY  - 2019
ER  - 

AU  - Johansen, Antony
AU  - Parker, Martyn
C7  - pp. 1329-1345
TI  - Hip Fracture and Orthogeriatrics
SN  - 9780470090558
UR  - https://doi.org/10.1002/047009057X.ch114
DO  - doi:10.1002/047009057X.ch114
SP  - 1329-1345
KW  - hip fracture
KW  - proximal femur fracture
KW  - fracture prevention
PY  - 2019
AB  - Summary This chapter contains sections titled: Background Diagnosis Classification Initial Management Fracture Repair Postoperative Care Medical Care Models of Orthogeriatric Collaboration Key References References
ER  - 
